| Home | Corporate Profile | Technology & Research | Investors | Glossary | Contact Us |
|
GROWTH HORMONE: METABOLISM AND CANCER PROGRAM Growth hormone (GH) has traditionally been studied and developed for states of GH deficiency or growth-related disorders. More recently, new information about the role of GH in metabolism and cell growth has triggered interest in a range of new therapeutic targets including lipid dysregulation, metabolic syndrome and cancer. |
NNZ-3006 NNZ-8000 |
| ©2008 Neuren Pharmaceuticals Limited |